A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection

• David Gardiner ,

  * E-mail: david.gardiner@bms.com

  Affiliation Bristol-Myers Squibb, Pennington, New Jersey, United States of America

  ⨯
• Jay Lalezari,

  Affiliation Quest Clinical Research, San Francisco, California, United States of America

  ⨯
• Eric Lawitz,

  Affiliation Alamo Medical Research, San Antonio, Texas, United States of America

  ⨯
• Michael DiMicco,

  Affiliation Advanced Clinical Research Institute, Anaheim, California, United States of America

  ⨯
• Rheem Ghalib,

  Affiliation The Liver Institute at Methodist Hospital, Dallas, Texas, United States of America

  ⨯
• K. Rajender Reddy,

  Affiliation University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Kyong-Mi Chang,

  Affiliations University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Mark Sulkowski,

  Affiliation Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Steven O’ Marro,

  Affiliation Springfield Clinic Infectious Diseases, Springfield, Illinois, United States of America

  ⨯
• Jeffrey Anderson,

  Affiliation Bristol-Myers Squibb, Pennington, New Jersey, United States of America

  ⨯
• Bing He,

  Affiliation Bristol-Myers Squibb, Pennington, New Jersey, United States of America

  ⨯
• Vikram Kansra,

  Current address: TESARO, Waltham, Massachusetts, United States of America

  Affiliation Bristol-Myers Squibb, Princeton, New Jersey, United States of America

  ⨯
• Fiona McPhee,

  Affiliation Bristol-Myers Squibb, Wallingford, Connecticut, United States of America

  ⨯
• Megan Wind-Rotolo,

  Affiliation Bristol-Myers Squibb, Princeton, New Jersey, United States of America

  ⨯
• Dennis Grasela,

  Affiliation Bristol-Myers Squibb, Pennington, New Jersey, United States of America

  ⨯
• Mark Selby,

  Affiliation Bristol-Myers Squibb, Milpitas, California, United States of America

  ⨯
• Alan J. Korman,

  Affiliation Bristol-Myers Squibb, Milpitas, California, United States of America

  ⨯
•  [ ... ],
• Israel Lowy

  Affiliation Regeneron Pharmaceuticals, Tarrytown, New York, United States of America

  ⨯
• [ view all ]
• [ view less ]